Pharmacokinetics and safety of cefamandole in newborn infants. 1979

M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans

Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase and eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012874 Skin Diseases, Infectious Skin diseases caused by bacteria, fungi, parasites, or viruses. Infectious Skin Diseases,Disease, Infectious Skin,Diseases, Infectious Skin,Infectious Skin Disease,Skin Disease, Infectious

Related Publications

M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
September 1978, Antimicrobial agents and chemotherapy,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
May 1993, Archives of disease in childhood,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
February 1983, Antimicrobial agents and chemotherapy,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
August 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
April 1982, Antimicrobial agents and chemotherapy,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
January 1993, Medicina,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
October 1984, Antimicrobial agents and chemotherapy,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
January 1984, Pediatric pharmacology (New York, N.Y.),
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
December 1982, Antibiotiki,
M M Agbayani, and A J Khan, and P Kemawikasit, and W Rosenfeld, and D Salazar, and K Kumar, and L Glass, and H E Evans
November 1976, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!